Vela Diagnostics Sequencing System for HIV-1 Genotype Testing
Key Takeaways
- Full and open competition - all businesses eligible to bid
- Work to be performed in FORT DETRICK, MD
- Industry: In-Vitro Diagnostic Substance Manufacturing
Contract Details
- Notice ID
- HT9426-26-NOI-5892
- Opportunity Type
- Special Notice
- Agency
- DEPT OF DEFENSE
- Sub-Agency
- DEFENSE HEALTH AGENCY (DHA)
- Office
- ARMY MED RES ACQ ACTIVITY
- Posted Date
- Wednesday, August 12, 2026
- Response Deadline
- Thursday, August 27, 2026
- PSC Code
- 6650
- Set-Aside
- Full & Open Competition
- Place of Performance
- FORT DETRICK, MD, 21702
- Status
- Active
Description
Notice of Intent (NOI) to Sole Source Title: Vela Sentosa SQ Next Generation Sequencing (NGS) for FDA Approved HIV-1 Genotype Sequencing Requiring Activity: Walter Reed Army Institute of Research (WRAIR) , Diagnostics and Countermeasures Branch (DCB) Related Notice: HT9426-26-RFI-5892 Product Service Code (PSC): 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets North American Industry Classification System (NAICS) Code: 325413 - In-Vitro Diagnostic Substance Manufacturing Small Business Size Standard: 1250 employees The Defense Health Agency Contracting Activity (DHACA) on behalf of the Diagnostics and Countermeasures Branch (DCB) at the Walter Reed Army Institute of Research (WRAIR) intends to award a Firm Fixed Price contract on a sole source basis to Vela Diagnostics,
Why This Opportunity Matters
The Department of DEFENSE is seeking responses for in-vitro diagnostic substance manufacturing in FORT DETRICK, MD.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts